comparemela.com

Latest Breaking News On - Globenewswire news - Page 1 : comparemela.com

Proposed Golimumab Biosimilar AVT05 Meets Primary Endpoints in Moderate to Severe RA

At the end of the trial, the study met its primary outcome, indicating therapeutic equivalence between the biosimilar (AVT05) and reference golimumab.

The Critical Role of Management Systems and Sensors in Road Safety

Metal Recycling and the Circular Economy

An A to Z of Industrial Robots

Industrial robotics has emerged as game-changers in various sectors, transforming manufacturing processes via advanced robots that combine precision, speed, and versatility, making them invaluable assets for businesses seeking to improve productivity and efficiency.

Intercept Cancels Plans For NASH Treatment After CRL

The treatment, developed by Intercept Pharmaceuticals, could not be approved in its present form, according to the CRL and any resubmission of the treatment for patients with NASH would require at least the successful completion of the long-term outcomes phase of the REGENERATE study.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.